What Makes Clascoterone Truly Unique
Clascoterone stands out as a topical treatment for male pattern baldness because it blocks dihydrotestosterone, or DHT, right at the androgen receptors in scalp hair follicles without spreading much into the rest of the body. This local action sets it apart from older drugs like finasteride, which are taken by mouth and lower DHT levels everywhere, often leading to side effects such as issues with sexual function.
At its core, male pattern baldness happens when DHT binds to receptors in hair follicles, causing them to shrink over time and produce thinner hair until they stop growing. Clascoterone, also called cortexolone 17alpha-propionate, works by sticking to those same receptors first, so DHT cannot attach and trigger the damage. Applied as a 5 percent solution twice a day on the scalp, it competes directly with DHT and testosterone at the follicle level.[1][2][3][4][6]
What makes this drug special is its design for minimal body-wide impact. It breaks down quickly if it enters the bloodstream, keeping hormone levels stable elsewhere. Early tests from its use as a 1 percent cream for acne, sold as Winlevi, showed no major changes in the body’s hormone system even after weeks of use. Recent phase 3 trials called SCALP 1 and SCALP 2, involving over 1,400 men, confirmed this with side effects like skin irritation matching those of a plain lotion, and no serious hormone disruptions in most cases.[1][4][6][7]
Those trials brought impressive results too. One study saw a 539 percent relative increase in hair count in treated areas compared to placebo, while the other showed 168 percent. Patients also reported noticing thicker hair. This points to real regrowth by protecting follicles and possibly boosting their activity, unlike minoxidil, which mainly improves blood flow but does not target DHT directly. Clascoterone could pair well with minoxidil for better outcomes.[2][4][6][7]
Unlike oral anti-androgens that reduce DHT production across the body, clascoterone acts only where needed, filling a gap for people who avoid pills due to risks. While some systemic effects like mild hormone axis changes appeared in higher doses, they reversed quickly after stopping. This targeted approach could make it a game-changer, especially as the first new topical option in decades aimed straight at the root cause of pattern baldness.[2][5][6]
Sources
https://www.ndtv.com/health/how-clascoterone-works-acne-drug-repurposed-for-male-pattern-baldness-explained-9770844
https://theprint.in/opinion/clascoterone-new-drug-root-cause-pattern-baldness/2813671/
https://trial.medpath.com/news/27b0a7ff93d6fdc7/cosmo-s-clascoterone-5-topical-solution-achieves-breakthrough-results-in-phase-iii-male-pattern-hair-loss-trials
https://hairgrowthdoctor.com/clascoterone-cure-hair-loss/
https://www.aditharun.com/p/clascoterone-is-not-a-cure-for-baldness
https://www.genengnews.com/topics/translational-medicine/stockwatch-cosmo-surges-40-on-baldness-candidates-phase-iii-data/
https://nuleafhair.com/blogs/what-cosmos-clascoterone-phase-iii-breakthrough-means-for-hair-restoration-patients/
